Markets:

Overview

News

Currencies

International

Treasuries

ADC Therapeutics SA Common Shares (NY:ADCT)

4.225 +0.005 (+0.12%)

Streaming Delayed Price Updated: 9:57 AM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about ADC Therapeutics SA Common Shares

< Previous 1 2 3 4 Next >

These stocks are moving in today's session ↗

December 03, 2025

Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Which stocks are gapping on Wednesday? ↗

December 03, 2025

The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

ADC Therapeutics (ADCT) Earnings Call Transcript ↗

November 10, 2025

ADC Therapeutics (ADCT) Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

Earnings Preview For ADC Therapeutics ↗

November 07, 2025

Via Benzinga

Preview: ADC Therapeutics's Earnings ↗

August 11, 2025

Via Benzinga

Preview: ADC Therapeutics's Earnings ↗

May 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 02, 2025

Via Benzinga

Top 5 Biotech Stocks With Strong Momentum ↗

August 28, 2025

Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.

Via Benzinga

Which stocks are moving on Wednesday? ↗

May 14, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Top movers analysis in the middle of the day on 2025-05-14: top gainers and losers in today's session. ↗

May 14, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

A Preview Of ADC Therapeutics's Earnings ↗

March 26, 2025

Via Benzinga

ADC Therapeutics's Earnings: A Preview ↗

November 06, 2024

Via Benzinga

Earnings Scheduled For August 12, 2025 ↗

August 12, 2025

Via Benzinga

Earnings Scheduled For May 14, 2025 ↗

May 14, 2025

Via Benzinga

A Preview Of ADC Therapeutics's Earnings ↗

March 12, 2024

Via Benzinga

Earnings Scheduled For March 27, 2025 ↗

March 27, 2025

Via Benzinga

ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why ↗

November 08, 2024

Stephens initiates coverage on ADC Therapeutics (ADCT), highlighting Zynlonta's potential in second-line DLBCL and a promising oncology pipeline. Overweight rating, $6 price target.

Via Benzinga

ADC Therapeutics - Time For A Turn-Around? ↗

February 27, 2024

ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates for patients suffering from hematological malignancies and solid tumors.

Via Talk Markets

ADCT Stock Earnings: ADC Therapeutics Beats EPS, Misses Revenue for Q2 2024 ↗

August 06, 2024

ADCT stock results show that ADC Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

7 Growth Stocks to Buy for Under $5 for Massive Gains ↗

July 11, 2024

Although growth stocks under $5 are inherently risky and unpredictable, their very nature also facilitates robust upside potential.

Via InvestorPlace

Intapp, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

July 08, 2024

Via Benzinga

Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget ↗

June 13, 2024

Since wealth without health is utterly meaningless, investors may have some confidence with these biotech stocks to buy.

Via InvestorPlace

ADCT Stock Earnings: ADC Therapeutics Beats EPS, Misses Revenue for Q1 2024 ↗

May 06, 2024

ADCT stock results show that ADC Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

May 06, 2024

Via Benzinga

Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

April 30, 2024

Via Benzinga

Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday ↗

March 13, 2024

U.S. stocks were mixed, with the Dow Jones index surging more than 100 points on Wednesday.

Via Benzinga

Topics Stocks

Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

February 20, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Earnings Scheduled For March 13, 2024 ↗

March 13, 2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.

Via Benzinga

The 3 Biotech Stocks That Could Make Your February Unforgettable ↗

February 15, 2024

After a blistering hot year of biotech M&A, we’ll see more of the same in 2024. That could be great news for these hot biotech stocks.

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

ADC Therapeutics SA Common Shares (NY:ADCT)

Headline News about ADC Therapeutics SA Common Shares

Starting at $3.75/week.

Subscribe Today